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Abstract
Background: The prevalence of imaged pathology in primary care has received little attention and the relevance
of identified pathology to symptoms remains unclear. This paper reports the prevalence of imaged pathology and
the association between pathology and response to diagnostic blocks into the subacromial bursa (SAB),
acromioclavicular joint (ACJ) and glenohumeral joint (GHJ).
Methods: Consecutive patients with shoulder pain recruited from primary care underwent standardised x-ray,
diagnostic ultrasound scan and diagnostic injections of local anaesthetic into the SAB and ACJ. Subjects who
reported less than 80% reduction in pain following either of these injections were referred for a magnetic
resonance arthrogram (MRA) and GHJ diagnostic block. Differences in proportions of positive and negative imaging
findings in the anaesthetic response groups were assessed using Fishers test and odds ratios were calculated a for
positive anaesthetic response (PAR) to diagnostic blocks.
Results: In the 208 subjects recruited, the rotator cuff and SAB displayed the highest prevalence of pathology on
both ultrasound (50% and 31% respectively) and MRA (65% and 76% respectively). The prevalence of PAR
following SAB injection was 34% and ACJ injection 14%. Of the 59% reporting a negative anaesthetic response
(NAR) for both of these injections, 16% demonstrated a PAR to GHJ injection. A full thickness tear of supraspinatus
on ultrasound was associated with PAR to SAB injection (OR 5.02; p < 0.05). Ultrasound evidence of a biceps
tendon sheath effusion (OR 8.0; p < 0.01) and an intact rotator cuff (OR 1.3; p < 0.05) were associated with PAR to
GHJ injection. No imaging findings were strongly associated with PAR to ACJ injection (p ≤ 0.05).
Conclusions: Rotator cuff and SAB pathology were the most common findings on ultrasound and MRA. Evidence
of a full thickness supraspinatus tear was associated with symptoms arising from the subacromial region, and a
biceps tendon sheath effusion and an intact rotator cuff were associated with an intra-articular GHJ pain source.
When combined with clinical information, these results may help guide diagnostic decision making in primary care.
Background
Shoulder pain is a common and disabling complaint.
The reported annual incidence of shoulder pain in pri-
mary care is 14.7 per 1000 patients per year [1] with a
lifetime prevalence of up to 70% [2]. Recovery from
shoulder pain can be slow and recurrence rates are high
with 25% of those affected by shoulder pain reporting
previous episodes, and 40 to 50% reporting persisting
pain or recurrence at 12-month follow-up [3-5].
The most common causes of shoulder pain in primary
care are reported to be rotator cuff disorders, acromio-
clavicular joint (ACJ) disease and glenohumeral joint
(GHJ) disorders [6], with classification of these disorders
based primarily upon results of clinical tests [1,7-11].
However, inconsistent diagnostic terminology [12], lack
of universally accepted diagnostic classification criteria
[13,14] and poor specificity of many physical examina-
tion tests [15] hamper confidence in classification sys-
tems that use clinical test criteria alone.
Diagnostic imaging investigations including shoulder x-
ray and diagnostic ultrasound imaging are increasingly
being utilised by primary care practitioners to aid
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such as magnetic resonance arthrogram (MRA) are also
available, providing improved visualisation of pathologies
such as glenoid labral lesions and tendon pathology [17].
While previous studies report the prevalence of imaging
findings in the general population [18], specific athletic
populations [19,20], samples of convenience [21,22] or
case-control comparisons for specific shoulder pathology
[23], the prevalence of imaged pathology in a prospective
cohort of primary care patients suffering a current epi-
sode of shoulder pain has not been previously reported.
Diagnostic decisions rely upon knowledge of prevalence
of a condition in specific populations in order to estimate
the likelihood of a positive ‘disease’ status or outcome
following specific tests or investigations [24]. Knowledge
of prevalence of imaged pathology in primary care would
provide prior probability for specific conditions, thus
assisting diagnostic decision-making processes and
assessment as to the value of expensive or invasive inves-
tigations or interventions.
The interpretation of imaging findings can be compli-
cated by the presence of anatomic variants [25,26] and
the high prevalence of asymptomatic pathology espe-
cially in ageing populations [18,21]. The prevalence of
asymptomatic full-thickness rotator cuff tears more than
doubles after the age of 50 years [18], and asymptomatic
ACJ arthritis has been identified by magnetic resonance
imaging (MRI) in 93% of individuals over the age of 30
years [21]. Despite widespread use of imaging investiga-
tions in primary care, the relationship between imaging
findings and symptoms has received limited attention.
Diagnostic injections of local anaesthetic provide a
method for determining whether symptoms arise from a
specific structure [27,28]. Following injection of local
anaesthetic into an anatomical structure, any subsequent
reduction in pain intensity can be measured to assess
the likelihood of its involvement in the patient’s symp-
toms [29-31].
The aims of this paper were to report the prevalence
of imaged shoulder pathology, and to evaluate the asso-
ciation between imaged pathology and a positive
response to diagnostic blocks in a consecutive sample of
patients with shoulder pain recruited from a primary
care setting.
Methods
Study design and setting
The results presented in this paper formed part of a
wider prospective, blinded diagnostic accuracy study in
which clinical examination and imaging variables (index
tests) were compared with results of diagnostic injec-
tions of local anaesthetic (reference standard) into the
SAB, ACJ and GHJ. Subjects were recruited consecu-
tively from a community-based medical centre and nine
physiotherapy practices across Christchurch, New
Zealand.
Ethical approval
The New Zealand Ministry of Health Regional Ethics
Committee (Upper South A) granted ethical approval in
May 2008.
Subjects
Consecutive patients presenting to their primary care
practitioner (general practiti o n e r( G P )o rp h y s i o t h e r a -
pist) for the first time with a new episode of shoulder
p a i n( F i g u r e1 ) ,w h ow e r eo v e r1 8y e a r so fa g ea n da b l e
to follow verbal instructions were eligible for inclusion
in the study. Exclusion criteria were known fractures or
dislocations around the shoulder complex, referred pain
from the cervical spine, sensory or motor deficit invol-
ving the upper limb, previous surgery to the shoulder or
cervical spine or contraindications to imaging or injec-
tion procedures.
Procedures
Subjects underwent a clinical examination (Additional
file_1) followed by a standard shoulder x-ray series, diag-
nostic ultrasound scan and imaging guided diagnostic
injections into the SAB and ACJ. Subjects reporting less
than 80% reduction in pain intensity from either of these
two injections were reviewed by a sports medicine physi-
cian prior to receiving an injection of local anaesthetic
into the GHJ, performed as part of a contrast-enhanced
MRA procedure. Study procedures are summarised in
Figure 2.
X-ray and diagnostic ultrasound scan
Subjects underwent a standardized series of shoulder
radiographs (x-ray) consisting of anterior-posterior (AP)
views in neutral, external and internal rotation, axial
view and outlet view [32]. X-rays were reported by
experienced musculoskeletal radiologists. A standardised
report form was used and radiologists recorded specific
abnormalities of the ACJ, acromion, GHJ and calcific
deposits. Imaging diagnostic criteria are presented in
Table 1.
Diagnostic ultrasound scans were performed by
trained and experienced musculoskeletal sonographers
and reported by fellowship trained musculoskeletal radi-
ologists. Examinations were performed using a Philips
IU22 machine with a 5-12 MHz linear array probe using
a standardised scan procedure [33,34]. The scan proce-
dure is described in Additional file_2.
The SAB was observed during dynamic abduction and
‘bunching’ under the acromion and the coracoacromial
ligament (CAL) was recorded. Subacromial bursal
dimensions were measured from the deep margin of
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tendon in all cases where this distance was measurable
(dimensions exceeding 1 mm).
Diagnostic injections
Subacromial bursa injection
Subjects were positioned supine with the arm in exter-
nal rotation. Under aseptic conditions, a 22-gauge nee-
dle was used to inject 5 mL of 1% lidocaine
hydrochloride (xylocaine™) into the SAB under ultra-
sound guidance using an anterior approach. When nee-
dle placement inside the SAB was confirmed by
ultrasound, the contents of the syringe were emptied
into the bursa. The radiologist recorded whether the
SAB was successfully infiltrated. A video of this proce-
dure may be viewed in Additional file 3_SAB injection,
compatible with Windows
® Media Player software.
Acromioclavicular joint injection
One week after the SAB injection, local anaesthetic was
injected into the ACJ under fluoroscopic guidance using
contrast enhancement. Subjects were positioned supine
with the arm in external rotation. Under aseptic condi-
tions, a 22-gauge needle was inserted into the ACJ using
a direct anterior approach. Iodinated contrast (0.5 ml of
Omnipaque 300 GE Healthcare) was introduced and
fluoroscopic images used to confirm needle placement
within the ACJ. Approximately 2 mL of 1% lidocaine
hydrochloride (xylocaine™) was then injected into the
joint. The radiologist recorded whether the ACJ was
successfully infiltrated and whether the injectate was
contained within the joint. A video of this procedure
may be viewed in Additional file 4_ACJ injection.
Glenohumeral joint injection
Approximately one week after the ACJ injection, sub-
jects reporting less than 80% relief from both the SAB
and ACJ injections underwent a GHJ arthrogram and
intra-articular injection of local anaesthetic and gadoli-
nium prior to magnetic resonance imaging (MRI). Sub-
jects were positioned supine and the GHJ injection
carried out under fluoroscopic guidance as described for
the ACJ injection (above) using 5 mL of iodinated con-
trast. A mixture of 0.5 mL gadolinium (0.5 mmol/ml
Gd-DOTA Guerbet France) and 10 mL 1% lidocaine
hydrochloride (xylocaine™) was injected into the joint.
The radiologist recorded whether the injectate was con-
tained within the joint. A video of this procedure may
be viewed in Additional file 5_GHJ injection.
Determination of post-injection change in pain intensity
Immediately prior to each injection, all subjects were
examined using up to six clinical tests identified as
being provocative of the subjects typical symptoms dur-
ing the initial clinical examination (Additional file_1).
Figure 1 Distribution of primary pain required for inclusion in the study.
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cal test on a 100 m visual analogue scale (VAS) where 0
mm indicated “no pain” and 100 mm represented
“worst imaginable pain”. Tests were repeated between 5
and 15 minutes following each injection and post-injec-
tion pain intensity VAS scores recorded again. The per-
centage change in pain intensity (anaesthetic response)
was calculated for each test [(post-injection VAS - pre-
Eligible for
inclusion
(373)
Not included in study:
did not wish to participate        50
exclusion criteria        57
unavailable on required days   31
symptoms resolved        15
study capacity exceeded        12
Total:       165
symptoms resolved 1
Symptoms resolved    1
Enrolled in
study
(208)
Clinical
examination
(207)
X-Ray & ultrasound
scan
(203)
SAB
injection
(202)
ACJ
injection
(188)
unable to get time off work 2
failed to arrive for procedure 2
pain flare - withdrew 4
failed to arrive for procedure 3
unavailable for procedure 3
fracture/dislocation 3
procedure unable to be performed
due to morbid obesity 1
GHJ  injection &
MR arthrogram
(93)
80% or more relief
from SAB or ACJ
injection
Exit study             77
Sports medicine
physician
consultation
(109)
unavailable for consultation               1
failed to arrive for consultation           1
withdrew for treatment intervention   6
symptoms resolved                  5
unavailable for procedure                  3
severe claustrophobia                  1
other health reasons                  1
DROP OUT REASONS
no
RESULTS of DIAGNOSTIC BLOCKS
SAB successfully infiltrated    202
post-injection pain change recorded 200
pre-injection pain intensity >20mm        4
included in analysis   196
80% PAR     66
ACJ infiltrated & injectate contained  173
pre-injection pain intensity >20mm     20
included in analysis   153
80% PAR     22
GHJ infiltrated & injectate contained    80
pre-injection pain intensity >20mm        7 
included in analysis     73
80% PAR     12
yes
Figure 2 Diagram showing study procedures, results of diagnostic blocks and dropout explanations.S A B ,s u b a c r o m i a lb u r s a ;P A R ,
positive anaesthetic response (≥80% post-injection reduction in pain intensity); ACJ, acromioclavicular joint; GHJ, glenohumeral joint; MR
arthrogram, magnetic resonance arthrogram. Numbers refer to the number (n) of subjects.
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Pathology Imaging Diagnostic Criteria
X-Ray
Acromioclavicular joint
arthropathy/degenerative
change
joint space narrowing, subchondral sclerosis, subchondral cystic change or marginal osteophytes.
osteolysis bony resorption or increased lucency in distal clavicle.
Glenohumeral joint
arthropathy/degenerative
change
joint space narrowing, subchondral sclerosis, subchondral cystic change or marginal osteophytes.
other loose bodies, joint calcifications.
Calcification of rotator cuff
components
supraspinatus calcific deposits adjacent to the greater tuberosity on AP-external rotation x-ray view.
infraspinatus calcific deposits adjacent to the greater tuberosity on AP-internal rotation x-ray view.
subscapularis calcific deposits in the anterior shoulder region on axial x-ray view.
Ultrasound
a
ACJ pathology Capsular hypertrophy, cortical irregularity or osteophytes, capsular bulge, joint space narrowing or widening.
Glenohumeral joint effusion more than 2 mm between posterior glenoid labrum and posterior capsule.
Rotator cuff
normal normal contour, normal echogenicity.
calcification focal increase in echogenicity with or without shadowing.
tendinosis tendon thickening or decreased echogenicity.
tear
intrasubstance hypoechoic change not extending to articular or bursal surface.
partial thickness SSp and ISp: hypoechoic change extending to either the articular or bursal surface. Subscapularis: partial fibre
discontinuity.
full thickness SSp and ISp: hypoechoic region extends from bursal to articular surface. Subscapularis: complete fibre discontinuity.
Subacromial bursa
bursitis hypoechoic fluid or effusion present and >1 mm thick.
bursal thickening ≥2 mm measured from deep margin of deltoid to superficial margin of supraspinatus.
“bunching” Fluid distension of the SAB or ‘buckling’ of the rotator cuff during abduction
MR arthrogram
a
Acromioclavicular joint
arthropathy/degenerative
changes
capsular hypertrophy with or without joint space narrowing, subchondral cystic change, bone marrow oedema or
osteophytes
osteolysis bony resorption or bone marrow oedema in the distal clavicle
Rotator cuff
normal normal contour, normal signal
tendinosis tendon thickening or mild increase in T2 signal
intrasubstance tear linear increase in T2 signal which does not extend to the articular or bursal surface.
partial thickness tear linear increase in T2 signal extending to the (bursal or articular) margins.
full thickness tear fluid signal intensity or contrast extending from the bursal to the articular side lesion of the rotator cuff. Contrast
seen in the SAB.
Subacromial bursitis increased T2 signal within the SAB
Glenohumeral joint
rotator interval pathology thickening, signal change or tear involving the biceps pulley, superior glenohumeral or coracohumeral ligament, or
synovitis in the rotator interval.
arthropathy/degenerative
change
chondral loss, subchondral sclerosis, cystic changes, bone marrow oedema or osteophytes
labral tear contrast extending into- or undermining the glenoid labrum, not conforming to normal variant anatomy.
Abbreviations: AP, antero-posterior view; ACJ, acromioclavicular joint; SSp, supraspinatus; ISp, infraspinatus; SAB, subacromial bursa;
adefinitions based upon accepted diagnostic criteria [33,35]
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cent change from all tests was then calculated. A post-
injection reduction in pain intensity of 80% or more was
used as the criterion for a positive anaesthetic response
(PAR). Subjects who did not reach an average of 80%
pain relief following the SAB and ACJ injection were
evaluated by a sports medicine physician and referred
for the MRA investigation.
Magnetic resonance arthrogram imaging
Magnetic resonance imaging was obtained within 30
minutes of the GHJ injection. Imaging was performed
with 3.0 Tesla General Electric-Milwaukee (GE) Signa
HDxt platform running version 15 software. A conven-
tional MR arthrography protocol was followed (Addi-
tional file_2) [35].
Blinding
The investigator performing the clinical examination
and pre- and post-injection clinical tests (AC) was
blinded to all diagnostic and treatment information
from referring practitioners and to results of imaging
procedures. Sonographers and radiologists were blinded
to all clinical information prior to the x-ray, ultrasound
scans and MRA procedure, and were blinded to results
of anaesthetic response to injections.
Sample size considerations
Sample size was estimated using methods described by
Flahault et al., (2005) [36]. Sample size was calculated
for the diagnostic sub-group with the lowest expected
prevalence (ACJ). The minimal acceptable lower confi-
dence limit was set at 0.75 and expected sensitivity/spe-
cificity were both set at 0.90. A review of sample size
estimates after the first 100 cases indicated lower than
expected prevalence of PAR to ACJ diagnostic block
and sample size was adjusted in order to maintain preci-
sion of diagnostic estimates.
Statistical analysis
The prevalence of imaged pathology and response to each
of the diagnostic blocks are reported as frequency and per-
centages. Contingency tables (2 × 2) were constructed and
Fishers exact test was used to compare proportions of
positive and negative imaging findings in the anaesthetic
response groups for each diagnostic injection procedure.
P-values of ≤0.05 were used to indicate statistical signifi-
cance. Odds ratios (OR) and 95% confidence intervals (CI)
for PAR to diagnostic blocks were calculated. Statistical
Package for the Social Sciences (SPSS) version 17.0 (IBM
®
Corporation 2010) was used for the analysis.
Due to the known limitations of VAS scales for mea-
suring change in pain intensity when pre-injection pain
levels are low (<20 mm) [37], only cases where pre-
injection pain intensity exceeded 20 mm were included
in the analysis of anaesthetic response to diagnostic
injections. Average percent change in pain intensity was
calculated for the index tests with positive integers indi-
cating increased post-injection pain intensity, and nega-
tive integers indicating decreased post-injection pain
intensity.
Results
Subjects
A total of 208 subjects were included in the study between
July 2009 and June 2010. Details of progression of subjects
through the study and dropout explanations are presented
in Figure 2. Demographic information for those included
in the study is presented in Table 2. There were no signifi-
cant differences between those included and excluded
from the study with respect to age or gender. Symptom
duration was shorter (median 2 weeks; IQ range 4 weeks)
in subjects excluded from the study (Mann-Whitney p <
0.001). There were no significant differences in demo-
graphic characteristics between the total sample and the
sub-group who received the GHJ injection as part of the
MRA procedure (p > 0.05).
Prevalence of imaged pathology
X-ray and ultrasound scan
The prevalence of the pathologies identified on x-ray
and ultrasound are presented in Figures 3 and 4. Acro-
mioclavicular joint (Figure 5a) and GHJ pathology were
the most common x-ray findings (both 17%) and calcifi-
cation involving the rotator cuff was reported in 13% of
subjects (Figure 5b).
Rotator cuff pathology was the most prevalent pathology
on ultrasound (50%), with supraspinatus the most com-
monly affected rotator cuff component, accounting for 86
of the 102 cases (85%) of rotator cuff pathology. Tears
were the most common pathology affecting supraspinatus
accounting for 52% of all supraspinatus pathology and
intrasubstance tears were the most common type of tear
accounting for 51% of all supraspinatus tears (Figure 6a).
Calcification was the most common finding in infraspina-
tus (59%) and subscapularis (69%) compared with 39% in
supraspinatus.
Prevalence of SAB pathology was 31% and bursal
thickening (dimensions exceeding 2 mm) was reported
in 23% of subjects (Figure 6b). Bunching of the SAB
under the acromion was observed in 84 subjects (43%)
(Figure 6c), and this was associated with reproduction of
symptoms in 72 subjects (86% of cases in which bunch-
ing was observed). Bunching under the CAL was
observed in 51 of the 94 cases (54%) in which this was
assessed, and was associated with reproduction of symp-
toms in 40 subjects (78% of cases in which bunching
was observed) (Figure 7).
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The prevalence of MRA findings is shown in Figure 8.
Only one case was reported as “normal” (no abnormality
reported) and 74% of cases demonstrated multiple
pathologies. The most commonly reported MRA finding
overall was SAB pathology (76%) with subacromial bur-
sitis reported in 68 subjects (73%) (Figure 9a). Rotator
cuff pathology affected at least one of the rotator cuff
components in 65% of cases. Supraspinatus was the
most frequently affected component of the rotator cuff
(85% of all rotator cuff pathology) and tears were the
most common pathological finding in all rotator cuff
components accounting for 41 of the 61 cases (67%) of
rotator cuff pathology. Partial thickness tears involving
the articular surface were the most common type of
supraspinatus tear identified (34% of all supraspinatus
tears) (Figure 9b). GHJ pathology (63%) and ACJ pathol-
o g y( 5 9 % )w e r ea l s oh i g h l yp r e v a l e n tw i t hr o t a t o ri n t e r -
val pathology (GHJ) and degenerative ACJ changes
(Figure 9c) (both 55%) the most common findings. Gle-
noid labrum tears were present in 47% of all subjects
who received the MRA and were associated with para-
labral cysts in 10 cases (23%). Suprascapular nerve com-
pression was associated with paralabral cysts in two
cases (2%) (Figure 9d).
Prevalence of anaesthetic response to diagnostic blocks
The anaesthetic response profiles for the diagnostic
injections are presented in Figure 10. There were no
observable differences in the frequency of imaged
pathology between those in whom post-injection pain
intensity increased compared with cases in which a
post-injection decrease in pain was reported. Results for
the injection procedures are presented in Figure 2. Infil-
tration of the SAB was confirmed in all cases and a
PAR (≥80% pain relief) was reported by 66 subjects
(34%) following the SAB injection. Average ACJ injec-
tion volume was 2.1 mL (SD 0.7 mL) and 22 of the 153
subjects (14%) in whom the injectate was contained
within the ACJ and whose pre-injection pain intensity
exceeded 20 mm on the 100 mm VAS scale reported an
80% PAR. Ninety three subjects received the GHJ injec-
tion as part of the MR arthrogram procedure and an
80% PAR was reported by 12 of the 75 subjects (16%) in
whom the injectate was contained within the GHJ and
pre-injection pain intensity exceeded 20 mm.
Association between imaged pathology and response to
diagnostic blocks
Imaging variables associated with PAR to diagnostic
block (p ≤ 0.05) and demonstrating a magnitude of
Table 2 Subject demographics
All subjects
(n = 208)
MRA group
(n = 93)
Subject characteristics Mean (SD) Range Mean (SD) Range
Age (years) 42 (14) 18-81 42 (14) 18-81
Height (cm) 172 (10) 147-199 172 (10) 151-198
Weight (kg) 80.6 (18.0) 50.3-189.0 82.3 (15.8) 52.7-125.3
Symptom duration (weeks)* 7 (13) 0-175 7 (13) 0-175
Worst pain previous 48 hours (100 mm VAS) 62 (23) 3-100 63 (24) 3-100
Average pain previous 48 hours (100 mm VAS) 37 (22) 1-100 37 (24) 1-100
n (%) n (%)
Male gender 107 (51) 53 (57)
Right hand dominant 110 (53) 79 (85)
Dominant arm affected 110 (53) 48 (52)
ACC Claim 193 (93) 86 (93)
Referrals
physiotherapist 203 (98) 89 (96)
general practitioner 5 (2) 4 (4)
Employment status
in paid employment 166 (80) 76 (82)
on modified duties due to shoulder pain 18 (9) 10 (11)
off work due to shoulder pain 7 (3) 4 (4)
not currently employed/working 41 (20) 17 (18)
Co-existent medical conditions 70 (34) 33 (36)
Current smoker 39 (19) 18 (20)
Abbreviations: MRA, magnetic resonance arthrogram; SD, standard deviation; VAS, visual analogue scale: ACC, Accident Compensation Corporation.
*symptom duration was not normally distributed. Figures presented are median (IQ range).
Cadogan et al. BMC Musculoskeletal Disorders 2011, 12:119
http://www.biomedcentral.com/1471-2474/12/119
Page 7 of 17association OR greater than 2.0 are summarised in
Table 3. Results for all other x-ray and ultrasound vari-
ables are presented in Additional file_6 (SAB and ACJ
injection) and Additional file_7 (GHJ injection). Results
for all other MRA variables are presented in Additional
file_8.
A full thickness supraspinatus tear identified by ultra-
sound imaging was associated with PAR to SAB injec-
tion (OR 5.0, p ≤ 0.05). None of the imaging variables
were strongly associated with PAR to ACJ injection (p >
0.05). The strongest association of any imaging variable
with diagnostic block was the association between
biceps tendon sheath effusion identified on ultrasound
and PAR to GHJ injection (OR 8.0; p < 0.01). A tear of
the rotator cuff reported on ultrasound was negatively
associated with a PAR to GHJ injection (p <0 . 0 5 ) .
When recoded, an ‘intact’ rotator cuff on ultrasound
demonstrated an OR of 1.3 for a PAR.
Discussion
This is the first report of the prevalence of imaged pathol-
ogy and anaesthetic responses to diagnostic injection into
the SAB, ACJ and GHJ in a sample of primary care
patients with shoulder pain. Estimates of the likelihood of
symptomatic pathologies being present that affect these
sites will increase or decrease as details from the history
and physical examination are added to the imaging find-
ings, but prior probability (prevalence) of these conditions
in the population of interest is the necessary baseline and
starting point [24]. This study provides the prior probabil-
ity data for specific pathologies and pain sources at the
80% pain reduction level in a sample of primary care
patients. This knowledge may help inform clinical deci-
sions regarding treatment interventions, the use of
advanced imaging or specialist referral.
Prevalence of imaged pathology
X-ray and diagnostic ultrasound scan
Shoulder x-rays were reported as ‘normal’ in 64% of
cases however the detection of three unsuspected frac-
tures in our study population highlights the use of x-ray
as a valuable screening tool. The prevalence of calcifica-
tion identified on x-ray (13%) was similar to previous
reports (10%) [38].
Subacromial bursa pathology was a common ultra-
sound finding (31%) in our symptomatic sample. We
Rotator cuff
- degenerative changes (8)
- other (2)
GHJ pathology
calcification 
n=26 (13%)
n=34 (17%)
Acromion Type
- Type I (flat) (88) Normal x-ray
ACJ pathology 
n=34 (17%) Type I (flat) (88)
- Type II (curved) (110)
- Type III (hooked) (4)
- Type IV (convex) (1)
Normal x ray
n= 131 (64%)
n=34 (17%)
- degenerative change (26)
- osteolysis (7)
- os acromiale (4)
other (4)
Fracture 
n=3 (6%) - greater tuberosity (2)
- other (4)
() greater tuberosity (2)
- reverse Bankart (1)
n=203
Figure 3 Prevalence of pathology identified on x-ray. n, number of cases; ACJ, acromioclavicular joint; GHJ, glenohumeral joint
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Page 8 of 17LHB pathology
n=35 (17%)
Normal US scan
n= 31 (15%) - paralabral cyst (3)
n=35 (17%)
- calcification (20)
- tear (10)f
- fluid in sheath (26)
- tear/tendinosis (6)
- subluxed (3)
- GHJ effusion (1)
-o t h e r  ( 2 )
Other
n= 6 (3%)
Subscapularis 
pathology
n=29 (14%)
tear (10)
- tendinosis (4)
SAB pathologya
n=63 (31%)
Infraspinatus pathology
n=12 (6%)
- calcification (9)
- tear (3)e
- tendinosis (1)
- thickened (47)b
- fluid/effusion (28)c
- calcification (4)
- bunching (acromion) (84)
Supraspinatus pathology
n=86 (42%)
t( 4 5 ) d
Rotator cuff pathology
- bunching (CAL) (51/94) 
- associated rotator cuff pathology (80)
- tear (45)d
- calcification (34)
- tendinosis (28)
(any cuff component)
n=102 (50%)
- any tear (53)
- calcification (49) ()
- tendinosis (30) n=203
Figure 4 Prevalence of pathology identified on ultrasound scan. (n), number of cases; US, ultrasound; GHJ, glenohumeral joint; SAB,
subacromial bursa; CAL, coracoacromial ligament; LHB, long head of biceps tendon.
aSubacromial pathology: any one of three present;
dimension ≥2 mm, fluid/effusion or calcification.
bSubacromial bursa dimensions: <1 mm (71); 1-2 mm (82); 2-3 mm (42); >3 mm (5).
cSubacromial bursal effusion associated with full thickness rotator cuff tear (7).
dSupraspinatus tears: intrasubstance (23); partial thickness-bursal
surface (4); partial thickness-articular surface (8); full thickness (10).
eInfraspinatus tears: intrasubstance (1); partial thickness (1); full thickness (1).
fSubscapularis tears: intrasubstance (5); partial thickness (4); full thickness (1).
Figure 5 Shoulder x-ray images of ACJ pathology and rotator cuff calcification. a) AP x-ray view in external rotation showing degenerative
acromioclavicular joint changes (white arrow); b) outlet view showing calcification in line with the infraspinatus tendon (black arrow).
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Page 9 of 17used the criterion of bursal dimension ≥2 mm, calcifica-
tion or bursal fluid or effusion or to classify ‘SAB
pathology’. Opinions vary regarding the dimension
(thickness) at which the normally thin hypoechoic line
o ft h eS A Bi sr e g a r d e da sp a t h o l o g i c a l .S o m eh a v es u g -
gested the ability to view and measure the SAB at all
represents pathological thickening [39], others consider
more than 2 mm thickness to be pathological [40-42]
and some suggest SAB thickness compared with the
unaffected side irrespective of bursal dimension to be of
more clinical relevance [43]. Recent theories question
whether SAB thickening is even pathological, proposing
it may be the result of adaptation to repeated overhead
activity [16]. Variable agreement (kappa 0.50 to 0.89)
has also been reported between musculoskeletal ultra-
sound experts for identification of SAB pathology on
ultrasound [44-47] with most disagreements relating to
variations in dynamic assessment and judgement of SAB
fluid as being normal or pathological [47]. Technicalities
surrounding the ultrasound diagnosis of SAB pathology,
lack of expert consensus upon the dimension at which
the SAB is considered pathological and the poor under-
standing of the relationship between SAB histopathology
and imaging findings mean that the reported prevalence
of SAB pathology on ultrasound is likely to vary. Bursal
bunching was also identified in a high proportion of
Figure 6 Ultrasound scan images of subacromial bursa and supraspinatus pathology. a) hypoechoic region (between calipers) indicating
an intrasubstance tear within posterior fibres of supraspinatus (longitudinal view) overlying the head of humerus (white arrowhead); b)
thickened subacromial bursa (calipers); c) bunching of the SAB (white arrow) under the acromion during dynamic abduction.
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abduction. SAB, subacromial bursa; US, ultrasound; CAL, coracoacromial ligament. Percentages are in reference to the number of cases in which
bursal bunching was assessed (acromion n = 195; CAL n = 94).
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Page 10 of 17subjects, however bunching was asymptomatic in 14%
(acromion) and 22% (CAL) of cases in which bunching
was observed. This highlights the need to correlate ima-
ging findings with clinical symptoms when considering
the diagnosis of ‘subacromial impingement’.
Magnetic resonance arthrogram
Magnetic resonance arthrogram findings in the sub-
group of subjects receiving the investigation, revealed a
high prevalence of multiple pathologies (74%), similar to
previous reports (77%) in an asymptomatic primary care
population [48]. In the subjects who received the MRA,
SAB and ACJ pathology were reported respectively in
76% and 59% of subjects, all of whom had previously
been classified as ‘non-responders’ at the 80% pain relief
level following injection of local anaesthetic into these
structures. Marrow oedema on MRI has been reported
as a reliable indicator of symptomatic ACJ pathology
[23]. Our study identified eight cases (9%) of active ACJ
arthropathy with marrow oedema in subjects who had
previously demonstrated a NAR to ACJ injection, how-
ever the inability of the local anaesthetic to penetrate to
the level of subchondral bone, thereby classifying those
subjects as ‘non-responders’ to ACJ injection, represents
a likely explanation for this result.
Rotator cuff pathology was reported in more than half
of subjects on both ultrasound and MRA with rotator
cuff tears identified in 26% and 44% of subjects with the
respective imaging procedures. Although no primary
care imaging studies are available for direct comparison,
these results are similar to previous reports of the
Subscapularis pathology p pg y
n=11 (12%)
- tear (6)i
- tendinosis (3)
LHB t /td i i
Infraspinatus pathology
n=14 (15%)
t( 7)h
LHB tear/tendinosis
n=6 (6%)
ACJ pathology
n=55 (59%)
- tear (7)h
- tendinosis (4)
- degenerative changes (51)a
active joint arthropathy (8)
Supraspinatus
pathology
n=52 (56%)
- active joint arthropathy (8)
- osteolysis (5)
- other (10)b
Rotator cuff 
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(any cuff component)
61 (65%)
- tear (35)g
- tendinosis (20)
SAB pathology
GHJ pathology
n=59 (63%)
- rotator interval pathology (51)c
- glenoid labrum tear (44)d
- isolated chondral lesion (17)
- tear (41)
- tendinosis (25)
n=71 (76%)
- bursitis (68)f
- bursitis associated with 
rotator cuff pathology (49)
thickened (15)
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- arthropathy/degenerative   
changes/OA (13)
- other (20)e
Normal MR - thickened (15)
- contrast seen in SAB (10)
n=93
Normal MR 
arthrogram
n=1 (1%)
Figure 8 Prevalence of pathology identified on MR arthrogram. (n), number of cases; LHB, long head of biceps tendon; ACJ, acromioclavicular
joint; GHJ, glenohumeral joint; OA, osteoarthritis; SAB, subacromial bursa;
aACJ degenerative changes: mild (28); moderate (18); severe (5).
bAcromioclavicular joint pathology - other: os acromiale (2); unfused acromial ossification centre (1); acromial spur (4); widened joint space/
subluxation (2); synovitis (1).
cRotator interval pathology: coracohumeral or superior glenohumeral ligament thickening (40); rotator interval synovitis
(39); biceps pulley, coracohumeral or superior glenohumeral ligament tear (13).
dGlenoid labrum tear: isolated labral tear (5); associated pathology
present (39); SLAP tear (20); SLAP Type II (17), Type III (2), Type IV (1); anterior-inferior tear (9); semi- or full circumferential tear (7); posterior-superior
tear (1); other tear (9); paralabral cyst (10); paralabral cyst causing suprascapular nerve compression (2).
eGlenohumeral joint pathology - other: bony
irregularity humeral head without marrow oedema (12); Hill-Sachs lesion (3); intra-articular/osseous body (3); ganglion cyst between coracoacromial
and coracohumeral ligaments (1); greater tuberosity fracture (1).
fSubacromial bursitis: mild (52); moderate (12); severe (4)
gSupraspinatus tears:
intrasubstance (11); partial thickness-bursal surface (5); partial thickness articular surface (12); full thickness (7).
hInfraspinatus tears: intrasubstance (4);
partial thickness (3); full thickness (0)
iSubscapularis tears: intrasubstance (4); partial thickness (0); full thickness (2)
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Page 11 of 17prevalence of rotator cuff tears in asymptomatic popula-
tions on ultrasound [18] and MRI [48]. Of interest was
the higher number of intrasubstance tears involving
infraspinatus, and partial thickness (articular surface)
supraspinatus tears identified on MRA compared with
the number identified on ultrasound imaging, despite
the smaller sample number in this subgroup. While
identification of an intrasubstance tear on MRA is unli-
kely to alter management at primary care level unless it
is associated with more serious pathology, partial thick-
ness tears of the rotator cuff are reported to be of prog-
nostic significance due to the high proportion that
increase in size or progress to full thickness tears if left
untreated [49]. Ultrasound imaging has previously
demonstrated only moderate pooled sensitivity (72%) for
detection of partial thickness rotator cuff tears com-
pared with MRI or surgery [50]. Variable agreement
among experts on the presence of partial thickness
rotator cuff tears on ultrasound (kappa 0.63; 88% to 92%
agreement) has also been reported [44,47,51]. Results of
MRI scans have been shown to alter clinical decisions
regarding management of rotator cuff tears in the ortho-
paedic setting [52] and MRA may therefore be indicated
at the primary care level if there is clinical suspicion of
rotator cuff disruption in the presence of equivocal
ultrasound findings.
T h ep r e v a l e n c eo fi n t r a - a rticular GHJ pathology on
MRA in this sub-group of subjects was also high (63%)
with rotator interval pathology (55%) and glenoid labral
tears (47%) the most common findings. However,
despite the high prevalence of GHJ pathology in this
study, only 16% of individuals were classified as respon-
ders to the GHJ injection at the 80% pain relief level.
During the MRA procedure, contrast was introduced
into the GHJ through the region of the rotator interval
and in some subjects the appearance of contrast in this
Figure 9 MR arthrogram images of shoulder pathology. a) subacromial bursitis - coronal PD fat saturated image showing region of
hyperintensity in the subacromial bursa (black arrow); b) partial thickness, articular surface supraspinatus tear (white arrow) - coronal T1 fat
saturated image showing contrast extending into the supraspinatus tendon. c) ACJ degenerative changes (white arrow) -coronal PD fat saturated
image; d) type III SLAP tear (white arrow) with contrast filling a paralabral cyst (black arrow) which extended into the supraglenoid and
suprascapular notch causing neural compression -coronal PD fat saturated image.
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Table 3 Summary of imaging variables demonstrating association with positive anaesthetic response to diagnostic
blocks (p ≤ 0.05 or OR >2.0)
Pathology identified on imaging Pathology
identified
(total cases) (n)
% with pathology present
reporting PAR
% with pathology absent
reporting PAR
OR
(95% CI)
Fishers
test
(p value)
SAB injection (PAR n = 66)
X-ray: type 3 acromion 4 75 33 6.2 (0.64, 61.23) 0.109
X-ray: os acromiale 4 75 33 6.1 (0.63, 60.25) 0.112
X-ray: supraspinatus calcification 16 56 31 2.8 (1.00, 7.97) 0.054
US: supraspinatus calcification 33 49 31 2.1 (1.00, 4.55) 0.068
US: supraspinatus FTT 10 70** 32 5.0 (1.25, 20.11) 0.033
ACJ injection (PAR n = 22)
X-ray: ACJ pathology 21 14 16 2.1 (0.69, 6.52) 0.189
US: supraspinatus tear PTT
(articular surface)
8 0 17 2.1 (0.39, 11.05) 0.323
US: LHB tendinosis 3 0 16 3.1 (0.27, 35.39) 0.374
GHJ injection (PAR n = 12)
US: no rotator cuff tear 19 21** 0 1.3 (1.11, 1.46) 0.029
US: supraspinatus tendinosis 11 27 14 2.3 (0.51, 10.30) 0.374
US: subscapularis tendinosis 3 33 15 2.8 (0.23, 33.27) 0.421
US: biceps tendon sheath effusion 13 46** 10 8.0 (2.02, 31.72) 0.004
MRA: ACJ pathology 46 20 11 2.0 (0.50, 8.23) 0.516
MRA: osteolysis lateral clavicle 5 40 15 3.9 (0.58, 26.58) 0.187
MRA: contrast seen in SAB 6 33 15 2.9 (0.47, 17.99) 0.254
Abbreviations: PAR, positive anaesthetic response (≥80% post-injection pain intensity reduction); OR, adjusted odds ratio; CI, confidence interval; SAB, subacromial
bursa; US, ultrasound; FTT, full thickness tear; ACJ, acromioclavicular joint; PTT, partial thickness tear; LHB, long head of biceps; GHJ, glenohumeral joint; MRA,
magnetic resonance arthrogram.
Percentages do not total 100% as these represent proportion of subjects with or without pathology on imaging (row percentages in contingency table) in the
PAR group. Negative anaesthetic response group results (column percentages) are not presented.
**p ≤ 0.05
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Page 13 of 17region on subsequent MRI films may have been difficult
to distinguish from mild rotator interval pathology. Gle-
noid labral tears are frequently associated with other
extra-articular pathology such as rotator cuff tears
[53-56], and the rotator interval also has complex
pathoanatomic relationships with supraspinatus, subsca-
pularis and the long head of biceps tendon [57]. The
high proportion of multiple pathology and low GHJ
PAR rate in this study may be partially explained by the
concurrent involvement of extra-articular structures.
Association between imaging findings and anaesthetic
response
Subjects with full thickness tears of supraspinatus identi-
fied by ultrasound imaging were more likely to experi-
ence a PAR to SAB injection than those without a full
thickness tear. Full thickness supraspinatus tears affect
the SAB-rotator cuff interface and infiltration of the
torn cuff with anaesthetic through this disruption is the
likely explanation for this finding. The small proportion
of PAR among those with an intrasubstance supraspina-
tus tear (intact margins) reported on ultrasound sup-
ports this theory, however none of the four cases in
which bursal-surface supraspinatus tears were identified
were classified as responders to the SAB injection. None
of the imaging variables were strongly associated with
PAR to ACJ injection. The high prevalence of asympto-
matic degenerative changes particularly in individuals
older than 30 years (93%) [21] may explain this result.
A long head of biceps tendon sheath effusion on ultra-
sound was significantly related to a PAR to GHJ injection.
The biceps tendon sheath is a synovial extension of the
GHJ capsule and may therefore be indicative of a GHJ
effusion resulting from intra-articular GHJ pathology or
systemic inflammatory disease. A biceps tendon sheath
effusion on ultrasound has been shown to be more sensi-
tive than arthrography for detection of intra-articular GHJ
pathology [58]. It is also a common finding in those suffer-
ing rheumatoid arthritis [59,60] and has been found to be
predictive of degenerative GHJ arthritis and polymyalgia
rheumatica [53,61]. In the current primary care study, half
the subjects with a biceps tendon sheath effusion reported
on ultrasound were classified as positive ‘responders’ to
the GHJ diagnostic block at the 80% pain reduction stan-
dard. The likely explanation for the PAR is the anaestheti-
sation of synovial tissue within the GHJ. Although this
finding may implicate an intra-articular pain source, it is a
non-specific result and further imaging investigations such
as MRI or laboratory tests would be required to identify
the specific pathology responsible for the synovial effusion.
The magnitude of association of the biceps tendon sheath
effusion on ultrasound with PAR to GHJ injection seen in
this study (OR 8.00), and a lower 95% confidence limit of
2.0 suggest this finding may be of value in the primary
care setting when considering further imaging investiga-
tion, laboratory testing or referral for higher levels of care.
Subjects with an intact rotator cuff on ultrasound also
demonstrated a higher proportion of PAR to GHJ injec-
tion (p < 0.05) than those in whom a rotator cuff tear was
identified. This could imply that in subjects with a rotator
cuff tear, the tear itself may have been more symptomatic
than any co-existent intra-articular GHJ pathology result-
ing in the NAR to GHJ diagnostic block. Although the OR
for PAR to GHJ injection in the presence of an intact rota-
tor cuff on ultrasound was small (1.27), the CI did not
include 1.0, and could represent a clinically meaningful
increase in the likelihood of a PAR since the prevalence of
this imaging finding was high (74%) [62]. Current guide-
lines advocate ultrasound imaging only when a major rota-
tor cuff tear is suspected when surgery may be considered
as a treatment option [63]. However, these results may
provide additional justification for the use of diagnostic
ultrasound imaging in the primary care setting to inform
decisions regarding further investigations for intra-articu-
lar GHJ pathology in the presence of an intact rotator cuff
and relevant clinical findings.
Limitations of the study
The definition of ‘accident’ in the context of subject
‘claim status’ in this study is influenced by New Zeal-
and’s’ unique Accident Compensation Corporation legis-
lation. Although the majority of subjects included in our
study had a current ACC claim, this does not necessarily
imply a significant degree of trauma, and complaints
included many less severe conditions with low levels of
functional disability. Those whose shoulder pain is not
covered by an ACC claim may, however, be less likely
to present for medical assessment and may be under-
represented in this study. Due to the cost of the MRA
procedures it was not possible for every subject to
undergo this procedure, and several subjects with high
and low levels of pain intensity withdrew from the study
prior to the MRA representing a potential source of
selection bias in this subgroup of subjects.
Conclusions
Rotator cuff and SAB pathology were the most common
findings on both ultrasound and on MRA in this pri-
mary care cohort. A full thickness supraspinatus tear on
ultrasound was associated with subacromial pain
according to our criterion, and ultrasound findings of a
biceps tendon sheath effusion and an intact rotator cuff
were associated with pain arising from the GHJ in a
subgroup of subjects. Results provide the prior probabil-
ity of imaged pathology, and when combined with clini-
cal examination findings may inform decisions in
primary care regarding treatment interventions and the
need for advanced diagnostic imaging or specialist
referral.
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fluoroscopic guidance.
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